Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • CYPRESS BIOSCIENCES INC Financial Overview

  • Income Statement: CYPB

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 17.16 M 13.94 M 3.22 M 18.76%
    Gross Profit 16.89 M 6.19 M 10.70 M 63.34%
    Net Income Before Extra Items/Preferred Div -18.23 M 3.49 M -21.71 M 119.14%
    Operating Income -10.38 M -3.80 M -6.58 M 63.42%
  • Cash Flow: CYPB

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 1.97 M 72.00 M -70.03 M -3,550.29%
    Net Cash Flow - Investing 19.81 M 37.42 M -17.61 M -88.91%
    Net Cash Flow/Operating Activities 231,071.00 2.81 M -2.58 M -1,117.72%
  • Balance Sheet: CYPB

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 174.59 M 182.70 M -8.11 M -4.64%
    Total Liabilities 14.68 M 14.68 M -7,557.00 -0.05%
    Shareholders Equity 159.92 M 168.02 M -8.10 M -5.07%
  • Key Ratios / Statistics: CYPB

    • Valuation

      Price/Earnings (TTM) -14.25
      Price/Sales (TTM) 15.04
      Price/Book (MRQ) 2.44
      Price/Cash Flow (TTM) -12.88
    • Profitability

      Gross Margin 98.44
      Operating Margin -60.51
      Profit Margin -106.22
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 18.30
      Current Ratio (MRQ) 13.34
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) -11.30
      Return on Assets (TTM) -15.90
      Return on Investments (TTM) -11.12